Advertisement

Selenium Deficiency Triggering Intractable Seizures

A Case Study
  • M. R. Calomme
  • V. Th. Ramaekers
  • W. Makropoulos
  • D. A. Vanden Berghe

Abstract

Diseases related to selenium deficiency are rare in humans. In some endemic areas of China, selenium deficiency secondary to low soil content contributes to the pathogenesis of Keshan cardiomyopathy (1). In the Western world, selenium deficiency has been reported after prolonged parenteral nutrition (2), and after dietary treatment for phenylketonuria, maple syrup urine disease and propionic acidaemia (3). The selenoenzyme glutathione peroxidase (GSH-Px) act as part of the protective mechanisms (4) against the ubiquitous formation of damaging oxygen radicals and catalyses the reduction of hydrogen peroxide and organic peroxides. Phospholipid hydroperoxide GSH-Px (PHGSH-Px) is membrane associated and reduces different phospholipid-hydroperoxides (4). Since the brain is deficient in catalase (5), the central nervous system can only be protected against hydrogen peroxide and lipid peroxidation by virtue of GSH-Px or PHGSH-Px.

Keywords

Selenium Concentration Short Bowel Syndrome Selenium Deficiency Selenium Status Maple Syrup Urine Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Y. Giangqui, G. Keyou, C. Junshi, C. Xiaoshu, World Rev. Nutr. Diet. 55, 98–152 (1988).Google Scholar
  2. 2.
    C.L. Kien, H.E. Ganther, Am.J.Clin. Nutr. 37, 319–328 (1983).Google Scholar
  3. 3.
    I. Lombeck, K.H. Ebert, K. Kasperek, L.E. Feinendegen, HJ. Bremer, Eur. J. Pediatr. 143, 99–102 (1984).CrossRefGoogle Scholar
  4. 4.
    B.A. Zachara, J. Trace Elem. Electrolytes Health Dis. 6, 137–151 (1992).Google Scholar
  5. 5.
    B. Halliwell, J.M.C. Gutteridge, TINS 8, 22–26 (1985).Google Scholar
  6. 6.
    M. Calomme, J. Hu, K. Van Den Branden, D. Vanden Berghe, Biol. Trace Elem. Res. 47, 379–383 (1995).CrossRefGoogle Scholar
  7. 7.
    M.R. Calomme, K. Van Den Branden, D.A. Vanden Berghe J.Appl. Bacteriology 79, 331–340 (1995).CrossRefGoogle Scholar
  8. 8.
    M.A. Beilstein, P.D. Whanger, J. Nutr. 116, 1711–1719 (1986).Google Scholar
  9. 9.
    R. Van Cauwenbergh, H. Robberecht, P. Van Dael, H. Deelstra, J. Trace Elem. Electrolytes Health Dis. 4, 127–131 (1990).Google Scholar
  10. 10.
    P. Van Dael, R. Van Cauwenbergh, H. Robberecht, H. Deelstra, M. Calomme, Atom. Spectroscopy 16, 251–255(1995).Google Scholar
  11. 11.
    E. Beutler, in Red cell metabolism, ed. Grune & Stratton, pp. 66-68 (1971).Google Scholar
  12. 12.
    V. Th. Ramaekers, M. Calomme, D. Vanden Berghe, W. Makropoulos, Neuropediatrics 25, 217–223 (1994).CrossRefGoogle Scholar
  13. 13.
    R. Cornells, A. Speecke, J. Hoste, Anal.Chim. Acta 78, 317–327 (1975).CrossRefGoogle Scholar
  14. 14.
    J. Nève, J. Trace Elem. Electrolytes Health Dis. 5, 1–17 (1991).Google Scholar
  15. 15.
    K. Kawakubo, M. Lida, T. Matsumoto, Y. Mochizuki, K. Doi, K. Aoyagi, M. Fujiishima, Postgrad. Med. J. 70, 215–219 (1994).CrossRefGoogle Scholar
  16. 16.
    R. Singh, D.N. Pathak, Epilepsia 31, 15–26 (1990).CrossRefGoogle Scholar
  17. 17.
    J.T. Coyle, P. Puttfarcken, Science 262, 689–695 (1993).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • M. R. Calomme
    • 1
  • V. Th. Ramaekers
    • 2
  • W. Makropoulos
    • 3
  • D. A. Vanden Berghe
    • 1
  1. 1.Department of Pharmaceutical SciencesUniversity of Antwerp (UIA)Belgium
  2. 2.Department of Paediatric NeurologyUniversity of AachenGermany
  3. 3.Department of Occupational HealthUniversity of AachenGermany

Personalised recommendations